Henry Schein (NASDAQ:HSIC) Posts Earnings Results, Beats Estimates By $0.01 EPS

Henry Schein (NASDAQ:HSIC) announced its earnings results on Tuesday. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01, Briefing.com reports. The company had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. Henry Schein updated its FY24 guidance to $4.70-$4.82 EPS and its FY 2024 guidance to 4.700-4.820 EPS.

Henry Schein Stock Up 5.2 %

Shares of NASDAQ HSIC traded up $3.33 during trading on Wednesday, reaching $67.25. The company had a trading volume of 255,848 shares, compared to its average volume of 1,194,523. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63. The stock has a market cap of $8.61 billion, a PE ratio of 22.59, a P/E/G ratio of 1.80 and a beta of 0.87. The business’s 50-day moving average is $67.84 and its 200 day moving average is $71.68. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47.

Analyst Ratings Changes

A number of equities analysts recently commented on HSIC shares. UBS Group decreased their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. Piper Sandler restated an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Barrington Research decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, Evercore ISI decreased their price objective on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a report on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $80.83.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.